Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.56 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | AOC3 | Q16853 | 4/20 | 0.48 |
| ▸ | DPP4 | P27487 | 2/20 | 0.44 |
| ▸ | F2 | P00734 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15916220 | 1.00 | KDM4E (0.56) | KDM4EADRA2AADRA2CLMNAHIF1A | |
| SCHEMBL605463 | 1.00 | KDM4E (0.56) | KDM4EADRA2AADRA2CLMNAHIF1A | |
| SCHEMBL1162359 | 1.00 | KDM4E (0.56) | KDM4EADRA2AADRA2CLMNAHIF1A | |
| SCHEMBL145000 | 1.00 | KDM4E (0.56) | KDM4EADRA2AADRA2CLMNAHIF1A | |
| SCHEMBL5043328 | 1.00 | KDM4E (0.56) | KDM4EADRA2AADRA2CLMNAHIF1A | |
| SCHEMBL2065907 | 1.00 | KDM4E (0.56) | KDM4EADRA2AADRA2CLMNAHIF1A | |
| SCHEMBL147622 | 1.00 | KDM4E (0.56) | KDM4EADRA2AADRA2CLMNAHIF1A | |
| Bromide SCHEMBL9771320 | 0.98 | KDM4E (0.54) | KDM4EADRA2AADRA2CLMNAHIF1A | |
| Hydrochloric Acid SCHEMBL9779186 | 0.98 | ALDH1A1 (0.57) | KDM4EADRA2AADRA2CLMNAHIF1A | |
| Benzoic Acid SCHEMBL6048463 | 0.87 | DAO (0.48) | KDM4EADRA2AADRA2CLMNAHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7071324-B2 | Systems and methods for sequencing by hybridization | BROWN UNIVERSITY RESEARCH FOUNDATION (US) | 2006-07-04 | — | — | US | claimed |
| US-20030064382-A1 | Systems and methods for sequencing by hybridization | NABSYS 2.0 LLC | 2003-04-03 | — | — | US | claimed |
| WO-2025133248-A1 | DIASTEREOMERIC AMINOALCOHOL AND AMINOETHER SALTS OF 2-[(4R,S)-8-FLUORO-2-[4-(3-METHOXYPHENYL)PIPERAZIN-1-YL]-3-[2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL]-3,4-DIHYDROQUINAZOLIN-4-YL]ACETIC ACID AND THEIR USE FOR ENANTIOMERIC SEPARATION | AIC246 AG & CO. KG (DE) | 2025-06-26 | — | — | WO | disclosed |
| EP-2895603-A1 | SERINOL PRODUCTION IN GLYCEROL CATABOLISM DEFICIENT ESCHERICHIA COLI STRAINS | BASF SE (DE) | 2015-07-22 | — | — | EP | disclosed |
| WO-2014040888-A1 | SERINOL PRODUCTION IN GLYCEROL CATABOLISM DEFICIENT ESCHERICHIA COLI STRAINS | BASF SE (DE) | 2014-03-20 | — | — | WO | disclosed |
| US-8247540-B2 | Caged nucleotides and oligonucleotides and their application | DEITERS ALEXANDER (US) | 2012-08-21 | — | — | US | disclosed |
| US-20100099159-A1 | CAGED NUCLEOTIDES AND OLIGONUCLEOTIDES AND THEIR APPLICATION | DEITERS ALEXANDER | 2010-04-22 | — | — | US | disclosed |
| US-20080247948-A1 | STEREOISOMERS OF FATTY ACID ANALOGS FOR DIAGNOSTIC IMAGING | MOLECULAR INSIGHT PHARMACEUTICALS, INC. | 2008-10-09 | — | — | US | disclosed |
| US-20080247948-A1 | STEREOISOMERS OF FATTY ACID ANALOGS FOR DIAGNOSTIC IMAGING | MOLECULAR INSIGHT PHARMACEUTICALS, INC. | 2008-10-09 | — | — | US | disclosed |
| US-7314609-B2 | Stereoisomers of fatty acid analogs for diagnostic imaging | MOLECULAR INSIGHT PHARMACEUTICALS, INC. (US) | 2008-01-01 | — | — | US | disclosed |
| US-7314609-B2 | Stereoisomers of fatty acid analogs for diagnostic imaging | MOLECULAR INSIGHT PHARMACEUTICALS, INC. (US) | 2008-01-01 | — | — | US | disclosed |
| US-20070128110-A1 | STEREOISOMERS OF FATTY ACID ANALOGS FOR DIAGNOSTIC IMAGING | MOLECULAR INSIGHT PHARMACEUTICALS,INC. | 2007-06-07 | — | — | US | disclosed |
| US-20070128110-A1 | STEREOISOMERS OF FATTY ACID ANALOGS FOR DIAGNOSTIC IMAGING | MOLECULAR INSIGHT PHARMACEUTICALS,INC. | 2007-06-07 | — | — | US | disclosed |
| US-7071324-B2 | Systems and methods for sequencing by hybridization | BROWN UNIVERSITY RESEARCH FOUNDATION (US) | 2006-07-04 | — | — | US | disclosed |
| WO-2004052876-A1 | SUBSTITUTED 4-PHENYL-[1,3]-DIOXANES | JANSSEN PHARMACEUTICA, N.V. (BE) | 2004-06-24 | — | — | WO | disclosed |
| US-20030064382-A1 | Systems and methods for sequencing by hybridization | NABSYS 2.0 LLC | 2003-04-03 | — | — | US | disclosed |
| US-5334712-A | Estrane or androstane pyridinyl alkyl or alkylphenyl amine steroids for antidiabetes and obesity | THE UPJOHN COMPANY (US) | 1994-08-02 | — | — | US | disclosed |
| EP-0101570-A1 | Method for the resolution of racemic 2-CP-difluoromethoxy phenyl)-3-methylbutyric acid | AMERICAN CYANAMID COMPANY (US) | 1984-02-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100099159-A1 | CAGED NUCLEOTIDES AND OLIGONUCLEOTIDES AND THEIR APPLICATION | RNGTT, NT5C3B, ADAR | KDM4E 4011/4885ADRA2A 2481/4885ADRA2C 3408/4885 |
| US-20080247948-A1 | STEREOISOMERS OF FATTY ACID ANALOGS FOR DIAGNOSTIC IMAGING | FFAR3, FFAR1, FFAR4 | KDM4E 4732/4885ADRA2A 1034/4885ADRA2C 1614/4885 |
| US-20070128110-A1 | STEREOISOMERS OF FATTY ACID ANALOGS FOR DIAGNOSTIC IMAGING | FFAR3, FFAR1, FFAR4 | KDM4E 4732/4885ADRA2A 1034/4885ADRA2C 1614/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.